Emerging Technology

Owlstone, FDA's OSEL partner to develop VOC ID methods
By LabPulse.com staff writers
Owlstone Medical entered a research collaboration agreement with the FDA's Center for Devices and Radiological Health Office of Science and Engineering Laboratories (OSEL) to develop methods of identifying volatile organic compounds (VOCs) in breath.
September 30, 2024
Molecule Social
Pathologists detect microplastics in human brain tissue
By Will Morton
Pathologists have detected microplastics in the olfactory bulb brain tissues of eight deceased individuals in Sao Paulo, highlighting the need for further research about their effects on human health, reports a study published in JAMA Network Open.
September 25, 2024
Olfactory Bulb Brain Cr Social
Rapid diagnostic test developed for ALS
By LabPulse.com staff writers
A blood diagnostic test for amyotrophic lateral sclerosis (ALS) has been developed that can rapidly distinguish ALS from conditions that mimic ALS in its early stages with a high level of specificity and sensitivity.
September 13, 2024
Nerve Neuron Axon Social
FDA approves Illumina IVD kit as CDx
By LabPulse.com staff writers
The U.S. Food and Drug Administration (FDA) has approved Illumina's TruSight Oncology Comprehensive cancer biomarker IVD kit for use as a companion diagnostic to match patients to two targeted therapies, Bayer's Vitrakvi and Lilly's Retevmo.
August 27, 2024
Regulatory File Submit Social
Danaher acquires Genedata
By LabPulse.com staff writers
The Basel, Switzerland-based Genedata, which develops software for biopharmaceutical and biotech R&D, said that it is joining Danaher's life sciences segment.
August 19, 2024
Business Handshake Intelligence Social
At-home heart failure screening device unveiled at ACS meeting
By LabPulse.com staff writers
A prototype heart-failure screening device that measures levels of two biomarkers for heart failure in as little as 15 minutes from a drop of saliva is being presented at the American Chemical Society (ACS) hybrid fall meeting.
August 20, 2024
Heart Pulmonary Trunk Social
Sophia Genetics platform receives CE Mark
By LabPulse.com staff writers
Software firm Sophia Genetics has received the CE Mark under the European Union's In Vitro Diagnostic Regulation for its Sophia DDM platform.
August 15, 2024
Dna Sequencing Data Analysis Social
Thermo Fisher gets FDA 510(k) clearance for HLA typing CDx
By LabPulse.com staff writers
Thermo Fisher's SeCore CDx HLA A Sequencing System has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for use as a companion diagnostic (CDx) with Adaptimmune's T-cell receptor therapy Tecelra for synovial sarcoma.
August 7, 2024
Fda Sign Dc Social
New laboratory developed tests for colorectal cancer screening get boost from CMS
By Liz Carey
Clinical laboratory test manufacturers aim for estimated 60 million unscreened Americans as CMS meets them with a broad CRC screening test definition and proposed coverage changes in 2025.
July 31, 2024
Colorectal Cancer Social
Sapio Sciences launches partnership program
By LabPulse.com staff writers
Lab informatics platform company Sapio Sciences has launched the Sapio Sciences Partner Program, a network of technology vendors, services companies, and resellers.
July 18, 2024
Business Hands Cooperation Social
EnsoData adds Resonea technology to sleep apnea platform
By LabPulse.com staff writers
EnsoData has acquired sleep diagnostic technology from Resonea that will add acoustic flow and microphone channels to its platform.
July 11, 2024
Sleep Apnea 2 Social
Proscia 510(k) adds muscle to Siemens Healthineers' Syngo Carbon pathology module
By Liz Carey
Regulatory approval and integration of Proscia's Concentriq AP-Dx pathology module into Siemens Healthineers' Syngo Carbon digital workspace unlocks new possibilities and efficiency gains for labs, Proscia CEO David West tells LabPulse.com.
July 8, 2024
David West.
Page 1 of 53
Next Page